Latest Cerebrospinal fluid Stories
LEXINGTON, Mass., Feb.
Three promising biomarkers being studied to detect Alzheimer's disease in its early stages appear to undergo a surprising shift as patients develop symptoms of dementia.
New study funded by RSRI in partnership with the Hydrocephalus Association will look at the role which brain compliance plays in pediatric hydrocephalus, a condition that is the leading cause
TSX: AMF TORONTO, Jan. 22, 2014 /CNW/ - Amorfix Life Sciences Ltd.
Measuring changes in certain proteins -- called biomarkers -- in people with amyotrophic lateral sclerosis may better predict the progression of the disease.
People in middle age who have a high blood pressure measure called pulse pressure are more likely to have biomarkers of Alzheimer's disease in their spinal fluid than those with lower pulse pressure.
A good night's rest may literally clear the mind. Using mice, researchers showed for the first time that the space between brain cells may increase during sleep, allowing the brain to flush out toxins that build up during waking hours.
Johns Hopkins researchers say that by measuring levels of certain proteins in cerebrospinal fluid (CSF), they can predict when people will develop the cognitive impairment associated with Alzheimer's disease years before the first symptoms of memory loss appear.
Alexis Rocciola hopes to raise awareness about hydrocephalus, an incurable brain condition she has been living with since birth, with the star who has inspired her the most, Taylor Swift, at her
- Growing in low tufty patches.